Role of 18F-FDG PET in demonstrating disease burden in patients with tuberculous meningitis

Journal of the Neurological Sciences

Volumn 370, Issue , 2016, Pages 196-200

  Gambhir, Sanjay ^a   Kumar, Mritunjai ^a   Ravina, Mudalsha ^a   Bhoi, Sanjeev Kumar ^a   Kalita, Jayantee ^a   Misra, U K ^a  

^a Sanjay Gandhi PGI Lucknow ^*  (India)

Author keywords

Imaging; MRI; Pet; PET scan; Tuberculosis; Tuberculous meningitis

Indexed keywords

ACETYLSALICYLIC ACID; ETHAMBUTOL; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; ISONIAZID; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; ECHOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET-CT SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; SENSITIVITY AND SPECIFICITY; SPINAL CORD; THORAX RADIOGRAPHY; TUBERCULOUS MENINGITIS; VERTEBRA; WHOLE BODY TOMOGRAPHY; YOUNG ADULT; ABDOMEN; BRAIN; COMPARATIVE STUDY; COST OF ILLNESS; DIAGNOSTIC IMAGING; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; SEVERITY OF ILLNESS INDEX;

ABDOMEN; ADOLESCENT; ADULT; BRAIN; COST OF ILLNESS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; SPINAL CORD; TUBERCULOSIS, MENINGEAL; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84988922621     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2016.09.051     Document Type: Article

References (20)

1. [1] Kelloff, G.J., Hoffman, J.M., Johnson, B., et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer. Research. 11:8 (2005), 2785–2808.
2. [2] Ichiya, Y., Kuwabara, Y., Sasaki, M., et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann. Nuclear. Med. 10:2 (1996), 185–191.
3. [3] Larson, S.M., Cancer or inflammation? A holy grail for nuclear medicine. J. Nucl. Med. 35:10 (1994), 1653–1655.
4. [4] Raviglione, M.C., Snider, D.E., Kochi, A., Global epidemiology of tuberculosis. Morbidity and mortality of a world wide epidemic. JAMA 273:3 (1995), 220–226.
5. [5] Wood, M., Anderson, M., Chronic Meningitis, Neurological Infections; Major Problems in Neurology. vol 16, 1998, WB Saunders, Philadelphia, 169–248.
6. [6] Kalita, J., Prasad, S., Misra, U.K., Predictors of paradoxical tuberculoma in tubercular meningitis. Int. J. Tuberc. Lung. Dis. 18:4 (2014), 486–491.
7. [7] British Medical Research Council, Streptomycin in tuberculosis trials committee: streptomycin treatment of tuberculous meningitis. Lancet 1:6503 (1948), 582–596.
8. 18F-FDG-PET/CT: a case report. Case. Rep. Oncol. 8:2 (2015), 226–232.
9. 18F-FDG PET/CT: incidentally detected and masquerading as relapse in a patient with ovarian Burkitt lymphoma. Clin. Nucl. Med. 40:7 (2015), 606–607.
10. [10] Kim, D.W., Kim, C.G., Park, S.A., Jung, S.A., Experience of dual time point brain F-18 FDG PET/CT imaging in patients with infectious disease. Nucl. Med. Mol. Imaging 44:2 (2010), 137–142.
11. [11] Kubota, R., Kubota, K., Yamada, S., Tada, M., Ido, T., Tamahashi, N., Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. Nucl. Med. 35:1 (1994), 104–112.
12. [12] Kim, D.W., Kim, C.G., Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region. Jpn. J. Radiol. 29:10 (2011), 682–687.
13. [13] Fukui, M.B., Blodgett, T.M., Snyderman, C.H., et al. Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics 25:4 (2005), 913–930.
14. [14] Barrington, S.F., Koutroumanidis, M., Agathonikou, A., et al. Clinical value of “ictal” FDG-positron emission tomography and the routine use of simultaneous scalp EEG studies in patients with intractable partial epilepsies. Epilepsia 39:7 (1998), 753–766.
15. [15] Rohren, E.M., Provenzale, J.M., Barboriak, D.P., Coleman, R.E., Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of noncentral nervous system malignancy. Radiology 226:1 (2003), 181–187.
16. 18F-FDG PET and PET/CT. Curr. Opin. Pulm. Med. 20:3 (2014), 287–293.
17. [17] Skoura, E., Zumla, A., Bomanji, J., Imaging in tuberculosis. Int. J. Infect. Dis. 32 (2015), 87–93.
18. [18] Bomanji, J.B., Gupta, N., Gulati, P., Das, C.J., Imaging in tuberculosis. Cold Spring Harbor Perspectives in Medicine, 5(6), 2015 pii: a017814.
19. [19] Sathekge, M., Maes, A., Van de Wiele, C., FDG PET imaging in HIV infection and tuberculosis. Semin. Nucl. Med. 43:5 (2013), 349–366.
20. 18F-FDGPET/CT in the initial assessment and for follow-up in patients with tuberculosis. Clin. Nucl. Med. 41:4 (2016), 187–194 (see comment in PubMed Commons below).